183 related articles for article (PubMed ID: 1823311)
1. HLA B51 antigen associated with neutrophil hyper-reactivity.
Sensi A; Gavioli R; Spisani S; Balboni A; Melchiorri L; Menicucci A; Palumbo G; Traniello S; Baricordi OR
Dis Markers; 1991; 9(6):327-31. PubMed ID: 1823311
[TBL] [Abstract][Full Text] [Related]
2. [Research for basic and clinical aspects of Behcet's disease--recent advance and future--].
Sakane T; Miura K
Nihon Rinsho; 1996 Mar; 54(3):870-84. PubMed ID: 8904250
[TBL] [Abstract][Full Text] [Related]
3. Failure to find a B51 IEF variant associated with Behçet's disease.
Baricordi OR; Melchiorri L; Balboni A; Perrone S; Pivetti-Pezzi P; Sensi A
Dis Markers; 1988; 6(4):275-7. PubMed ID: 3233883
[TBL] [Abstract][Full Text] [Related]
4. New perspective on Behçet's disease.
Sakane T
Int Rev Immunol; 1997; 14(1):89-96. PubMed ID: 9203029
[TBL] [Abstract][Full Text] [Related]
5. Contribution of Hla-B51 in the susceptibility and specific clinical features of Behcet's disease in Tunisian patients.
Hamzaoui A; Houman MH; Massouadia M; Ben Salem T; Khanfir MS; Ben Ghorbel I; Miled M
Eur J Intern Med; 2012 Jun; 23(4):347-9. PubMed ID: 22560383
[TBL] [Abstract][Full Text] [Related]
6. HLA-B27 and HLA-B51 determination in Tunisian healthy subjects and patients with suspected ankylosing spondylitis and Behçet's disease.
Sakly N; Boumiza R; Zrour-Hassen S; Hamzaoui A; Ben Yahia S; Amara H; Khairallah M; Mahjoub S; Bergaoui N; Ghedira I
Ann N Y Acad Sci; 2009 Sep; 1173():564-9. PubMed ID: 19758200
[TBL] [Abstract][Full Text] [Related]
7. Changes of neutrophil migration without modification of in vitro metabolism and adhesion in Behçet's disease.
Carletto A; Pacor ML; Biasi D; Caramaschi P; Zeminian S; Bellavite P; Bambara LM
J Rheumatol; 1997 Jul; 24(7):1332-6. PubMed ID: 9228133
[TBL] [Abstract][Full Text] [Related]
8. Association of MICA alleles and HLA-B51 in Italian patients with Behçet's disease.
Salvarani C; Boiardi L; Mantovani V; Olivieri I; Ciancio G; Cantini F; Salvi F; Malatesta R; Molinotti C; Govoni M; Trotta F; Filippini D; Paolazzi G; Viggiani M
J Rheumatol; 2001 Aug; 28(8):1867-70. PubMed ID: 11508592
[TBL] [Abstract][Full Text] [Related]
9. A weak association of HLA-B*2702 with Behçet's disease.
Gül A; Uyar FA; Inanç M; Ocal L; Barrett JH; Aral O; Koniçe M; Saruhan-Direskeneli G
Genes Immun; 2002 Sep; 3(6):368-72. PubMed ID: 12209364
[TBL] [Abstract][Full Text] [Related]
10. HLA-B51 may serve as an immunogenetic marker for a subgroup of patients with Behçet's syndrome.
Chajek-Shaul T; Pisanty S; Knobler H; Matzner Y; Glick M; Ron N; Rosenman E; Brautbar C
Am J Med; 1987 Oct; 83(4):666-72. PubMed ID: 3314492
[TBL] [Abstract][Full Text] [Related]
11. Association of HLA-B51 subtypes and Behçet's disease in Spain.
González-Escribano MF; Rodríguez MR; Walter K; Sanchez-Roman J; García-Lozano JR; Núñez-Roldán A
Tissue Antigens; 1998 Jul; 52(1):78-80. PubMed ID: 9714478
[TBL] [Abstract][Full Text] [Related]
12. Excessive function of peripheral blood neutrophils from patients with Behçet's disease and from HLA-B51 transgenic mice.
Takeno M; Kariyone A; Yamashita N; Takiguchi M; Mizushima Y; Kaneoka H; Sakane T
Arthritis Rheum; 1995 Mar; 38(3):426-33. PubMed ID: 7880197
[TBL] [Abstract][Full Text] [Related]
13. T cell epitope expression of mycobacterial and homologous human 65-kilodalton heat shock protein peptides in short term cell lines from patients with Behçet's disease.
Pervin K; Childerstone A; Shinnick T; Mizushima Y; van der Zee R; Hasan A; Vaughan R; Lehner T
J Immunol; 1993 Aug; 151(4):2273-82. PubMed ID: 7688396
[TBL] [Abstract][Full Text] [Related]
14. Human leukocyte antigen serologic and DNA typing of Behçet's disease and its primary association with B51.
Mizuki N; Inoko H; Mizuki N; Tanaka H; Kera J; Tsuiji K; Ohno S
Invest Ophthalmol Vis Sci; 1992 Nov; 33(12):3332-40. PubMed ID: 1358857
[TBL] [Abstract][Full Text] [Related]
15. Pathogenic gene responsible for the predisposition of Behçet's disease.
Mizuki N; Inoko H; Ohno S
Int Rev Immunol; 1997; 14(1):33-48. PubMed ID: 9203025
[TBL] [Abstract][Full Text] [Related]
16. SUMO4 gene polymorphisms in Chinese Han patients with Behcet's disease.
Hou S; Yang P; Du L; Zhou H; Lin X; Liu X; Kijlstra A
Clin Immunol; 2008 Oct; 129(1):170-5. PubMed ID: 18657476
[TBL] [Abstract][Full Text] [Related]
17. The relationship between plasma homocysteine level and HLA-B51 in patients with Behcet's disease: a case-control study.
Shadmanfar S; Shahram F; Nadji A; Akhlaghi M; Faezi ST; Sadeghi-Abdollahi B; Faridar A; Madanchi N; Davatchi F
Int J Rheum Dis; 2014 May; 17(4):466-70. PubMed ID: 24428874
[TBL] [Abstract][Full Text] [Related]
18. Familial Behçet's disease.
Akpolat T; Koç Y; Yeniay I; Akpek G; Güllü I; Kansu E; Kiraz S; Ersoy F; Batman F; Kansu T
Eur J Med; 1992 Nov; 1(7):391-5. PubMed ID: 1341477
[TBL] [Abstract][Full Text] [Related]
19. Immunogenetic studies of Behçet's disease.
Mizuki N; Ohno S
Rev Rhum Engl Ed; 1996; 63(7-8):520-7. PubMed ID: 8896070
[TBL] [Abstract][Full Text] [Related]
20. The novel -G646A polymorphism of the TNFalpha promoter is associated with the HLA-B51 allele in Korean patients with Behçet's disease.
Chang HK; Jang WC; Park SB; Nam YH; Lee SS; Park YW; Kim SK
Scand J Rheumatol; 2007; 36(3):216-21. PubMed ID: 17657677
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
